Christofides Anna, Schauer Claudia, Sharieff Waseem, Zlotkin Stanely H
Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Chronic Dis Can. 2005 Fall;26(4):114-20.
Iron deficiency anemia (IDA) is a significant public health problem among Canadian Aboriginal children. The objectives of this study were to determine the acceptability and safety of microencapsulated-iron sprinkles, a new powdered form of iron packaged in a single-serving sachet for prevention of IDA. A total of 102 non-anemic children aged 4 to 18 months from three communities were randomized to receive sprinkles containing 30 mg Fe/day (NR = 49) or placebo (NR = 53) for six months. To assess acceptability, adherence and side effects were monitored bi-weekly. To assess safety, serum ferritin (SF) concentration and anthropometry were measured at baseline and end. Mean adherence was 59.6 +/- 27.7 percent. There were no differences in adherence, SF, anthropometric status or side effects between groups. Although there were no differences in hemoglobin (Hb) concentration and anemia prevalence from baseline to end and between groups, the Hb curve shifted to the right (increased) for the sprinkles group and to the left (decreased) for the placebo group. Sprinkles may provide a safe and acceptable option to the current standard of care (i.e. ferrous sulphate drops) for the provision of iron in Canadian Aboriginal populations.
缺铁性贫血(IDA)是加拿大原住民儿童中一个严重的公共卫生问题。本研究的目的是确定微囊化铁剂洒剂(一种新型的铁剂粉末,包装在单份小袋中用于预防IDA)的可接受性和安全性。来自三个社区的102名4至18个月的非贫血儿童被随机分为两组,一组接受每日含30毫克铁的洒剂(n = 49),另一组接受安慰剂(n = 53),为期6个月。为评估可接受性,每两周监测一次依从性和副作用。为评估安全性,在基线和结束时测量血清铁蛋白(SF)浓度和人体测量指标。平均依从性为59.6 +/- 27.7%。两组在依从性、SF、人体测量状况或副作用方面没有差异。尽管从基线到结束以及两组之间血红蛋白(Hb)浓度和贫血患病率没有差异,但洒剂组的Hb曲线向右移动(升高),安慰剂组的Hb曲线向左移动(降低)。对于加拿大原住民人群,洒剂可能是目前护理标准(即硫酸亚铁滴剂)补铁的一种安全且可接受的选择。